Screening for Silent Myocardial Ischemia in Diabetic Patients
Author Information
Author(s): Lièvre Michel M, Moulin Philippe, Thivolet Charles, Rodier Michel, Rigalleau Vincent, Penfornis Alfred, Pradignac Alain, Ovize Michel
Primary Institution: Lyon 1 University
Hypothesis
Does screening asymptomatic diabetic patients for silent ischemia reduce cardiovascular events compared to usual care?
Conclusion
Systematic detection of silent ischemia in high-risk asymptomatic diabetic patients does not significantly improve outcomes compared to usual care.
Supporting Evidence
- Follow-up was complete for 98.9% of patients regarding mortality.
- Silent ischemia was detected in 21.5% of the screening group.
- There was no significant difference in primary outcomes between the screening and usual care groups.
Takeaway
The study looked at whether checking for heart problems in people with diabetes who don't have symptoms helps them live longer or healthier. It found that it doesn't really make a difference.
Methodology
A randomized, open, blinded end-point multicenter trial with 3.5 years of follow-up in 631 diabetic patients across 45 hospitals.
Potential Biases
The open-label design may have influenced treatment decisions, although randomization was centralized.
Limitations
The study was stopped early due to recruitment difficulties and a lower-than-expected event rate, leading to insufficient power.
Participant Demographics
Patients were aged 63.9 ± 5.1 years, with diabetes and at least 2 additional cardiovascular risk factors.
Statistical Information
Confidence Interval
95%CI 0.59 to 1.71
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website